cvd

  1. madman

    Is Venous Thromboembolism a Real Risk in TRT?

    8th Annual Meeting of the Androgen Society 2026 presentations from the top experts in the field! Wayne JG Hellstrom * Definite need for large, long term, multicenter, prospective RCT in the general hypogonadal population to determine the true risks of increased Hct as a side effect of TRT...
  2. madman

    Dr. Morgentaler - Hematocrit and Testosterone

    00:00-9:35 https://www.excelmale.com/threads/understanding-testosterone-and-myth-busting-with-dr-abraham-morgentaler.34957/#post-315464 * While the precise mechanism underlying secondary polycythemia in the setting of TTh is still debated, it is likely that a longer duration of...
  3. madman

    Testosterone and Calcified Plaque Volume

    8th Annual Meeting of the Androgen Society 2026 presentations from the top experts in the field! Matthew Budoff Manopause?! https://www.excelmale.com/threads/testosterone-and-cardiovascular-risk-the-traverse-trial-and-results-from-the-new-fda-label-change.32221/...
  4. madman

    SynAIRgy: The First Pill for Sleep Apnea? A Phase 3 Trial of AD109

    * This randomized, double-blind, placebo-controlled trial evaluated AD109, an investigational combination of aroxybutynin and atomoxetine, in adults with obstructive sleep apnea who could not or would not use positive airway pressure therapy. AD109 improved the apnea-hypopnea index and measures...
  5. madman

    Renal Denervation for Uncontrolled Hypertension

    In this excerpt from Tall Rounds®, Luke Laffin, MD, provides an overview of the science behind denervation and significant clinical trials.
  6. madman

    Testosterone Undecanoate Significantly Reduces LDL Cholesterol and Triglycerides in Men With Adult-Onset Testosterone Deficiency

    https://onlinelibrary.wiley.com/doi/10.1111/andr.70393 Table 1. Serum TT and lipids at baseline and final assessment in the total cohort stratified by TU and statin treatment. Table. 2 Lipid values at baseline and follow-up (24. 48, 72 and 96 months) in men with a follow-up duration...
  7. madman

    Can Diabetes Cause Erectile Dysfunction? What Treatments Can Help?

    Diabetes and erectile dysfunction: what can erection problems reveal about your health—and what treatments are available? In this video, a patient with type 2 diabetes shares his experience of erectile difficulties during a consultation with Professor Éric Allaire, a vascular and endovascular...
  8. madman

    Ceramide Risk Score: How to Incorporate it Into Your CV Prevention Practice

    Guest: Vlad Vasile, M.D., Ph.D.Host: Stephen L. Kopecky, M.D. Ceramides score is a blood test used to assess the risk of heart attacks and stroke. Most patients evaluated for cardiovascular risk benefit from this test, particularly patients deemed at intermediate risk by other assessments...
  9. madman

    New Pavlov Study Could Help Sleep Apnea Patients Rest Easier

    Obstructive sleep apnea (OSA) is a condition that affects millions globally, causing daytime sleepiness, lack of oxygen, and higher risks of developing cardiac issues. A new randomized control trial, called the Pavlov study, evaluated the efficacy and long-term conditioning effects of a...
  10. madman

    Getting to the Heart of Prostate Cancer: Identifying and Managing CV Risk in Patients Receiving ADT

    Educational Objectives In this activity, experts in prostate cancer discuss cardiovascular risk in patients receiving androgen-deprivation therapy (ADT). Upon completion of this activity, participants should be better able to: Evaluate the impacts of prostate cancer and ADT on...
  11. madman

    Updates in Clinical Management of Atrial Fibrillation

    Atrial Fibrillation You have atrial fibrillation, now what? Outline: Clinical Updates in AF AF: Final thought
  12. madman

    AHA Finally Comes Out in Favor of Coffee

    In this presentation, F. Perry Wilson, MD evaluates the latest scientific statement from the American Heart Association regarding caffeine and cardiovascular disease. The analysis breaks down recent clinical evidence examining how daily coffee consumption influences long-term cardiac outcomes...
  13. madman

    Association of testosterone and testosterone replacement therapy with atrial fibrillation

    * Treatment should be embedded in structured monitoring of hematocrit, blood pressure, renal and hepatic function, and cardiac rhythm, and coupled with active management of coexisting obesity, sleep apnea, diabetes, hypertension, and dyslipidemia, each of which independently influences AF risk...
  14. madman

    Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men

    * Despite these limitations, this study provides a large-scale, head-to-head comparison of men receiving testosterone therapy with vs without evidence of hypogonadism, with up to 10 years of follow-up, race/ethnicity stratification, rigorous propensity-score matching, and complementary modelling...
  15. madman

    DEBATE: Does Testosterone Therapy increase cardiac risk?

    * Dr. Patel emphasizes that real-world prescribing often differs from controlled trial conditions, particularly with injectable formulations that may result in higher testosterone peaks and greater hematologic effects. * Dr. Patel stresses the need for careful cardiovascular screening, patient...
  16. madman

    Testosterone replacement therapy and cardiovascular safety in older men: lessons from TRAVERSE and beyond

    * TRT does not increase MACE risk in men with confirmed organic hypogonadism when titrated to physiological levels. Non-MACE signals warrant vigilance rather than contraindication. Metabolic optimisation should precede TRT in functional hypogonadism. Individualised monitoring and careful patient...
  17. madman

    Is Your ED A Symptom Of Something Deadly? The Truth About Heart & Hormone Health - Roundtable

    Must listen here! Most men think erectile dysfunction is a bedroom problem and low testosterone is just a fact of getting older. This roundtable makes the case that both are early warning lights for your heart, your metabolism, and your long-term health and that ignoring them can cost...
  18. madman

    What a Cardiac CT Actually Shows. | Explained by a Doctor Who's Read 100,000 Scans

    * Clear Heart was built to solve that problem, offering direct-to-consumer self-pay access alongside physician referrals, with no 6-week hospital wait and results within 24 hours What does a cardiac CT scan actually show? In this video, Dr. Matthew Budoff - Professor of Medicine at the...
  19. madman

    Unlocking the Potential of Incretin-Based Therapies in T2D

    Incretin-Based Therapies Goals for Today
  20. madman

    Penis Health, What Every Man Needs to Know - Dr. Amy Pearlman

    Most men think erectile dysfunction is a bedroom problem. It's actually one of the earliest warning signs of cardiovascular disease, capable of showing up three to five years before a heart attack.In this episode, Dr. Gabrielle Lyon sits down with Dr. Amy Pearlman, a urologist trained in...
  21. madman

    2026 Guideline on the Management of Dyslipidemia

    https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423
  22. madman

    Pictures are Worth a 1000 Words: Role of Imaging in CV Risk Assessment

  23. madman

    Thrombotic Events and Essential Thrombocythemia/Polycythemia Vera: What You Should Know

    In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: Overview • PV and ET increase the risk of both arterial and venous thrombotic...
  24. madman

    Cracking the Code With Coronary Artery Calcium (CAC)

    How do you turn your patients' calcium scores into clear, personalized prevention plans?
  25. madman

    Start ED Meds Early: PDE5 Inhibitors Within 1 Month Linked to Lower Heart Risk and Mortality

    Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed hazard ratio and 1-year outcome of major adverse cardiac events (MACE) to depending on...
  26. madman

    ED Medications in Kidney Failure: PDE5 Inhibitors Linked to Lower Mortality and Heart Risk in ESRD

    Abstract INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED) affects over 70% of men with end-stage renal disease (ESRD), yet the cardiovascular safety of phosphodiesterase type 5 inhibitors (PDE5i) in this population remains poorly understood. Concerns persist due to altered...
  27. madman

    Daily Cialis (Tadalafil) After ED Diagnosis: Lower Risk of Heart Events and Death Over 3 Years

    Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed risk ratios and outcome of major adverse cardiovascular to depending on different period...
  28. madman

    What can erectile dysfunction say about men’s health?

    https://www.cbc.ca/listen/cbc-podcasts/410-the-dose/episode/16210375-what-can-erectile-dysfunction-say-about-mens-health Erectile dysfunction is commonly thought of as a sexual health issue, but experts say the condition can reveal a lot about men's health. Dr. Dean Elterman, a urologist at the...
  29. madman

    Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk

    https://www.nejm.org/doi/abs/10.1056/NEJMra2202438
  30. madman

    Controversies with Testosterone Replacement Therapy

    Dr. Khera of course! * if you prescribe testosterone there are five controversies you have to know about! Mohit Khera, MD, MBA, MPH Professor of Urology F. Brantley Scott Chair in Urology Director, Laboratory for Andrology Research Faculty Group Practice Medical Director Baylor College...
  31. madman

    ISSWSH 2026 Recap: Testosterone, Research Funding & Women's Sexual Pleasure

    Sexual medicine is underfunded, misunderstood, and often dismissed. But it's also one of the most collaborative fields in healthcare. Dr. Tami Rowen and I recap this year's ISSWSH conference and what it revealed about where the field is heading. Dr. Tami Rowen is an associate professor of OBGYN...
Back
Top